Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart
- 1 March 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (6) , 807-812
- https://doi.org/10.1016/0002-9149(85)90161-4
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Metabolism of flecainideThe American Journal of Cardiology, 1984
- Electrophysiologic actions of O-demethyl encainide: an active metabolite.Circulation, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasThe American Journal of Cardiology, 1983
- Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.Heart, 1982
- Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.Circulation, 1982
- Selection of an antiarrhythmic drug for a sudden-death-prevention trialAmerican Heart Journal, 1982
- Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainideThe American Journal of Cardiology, 1981
- Clinical electrophysiologic study of antiarrhythmic properties of flecainide: Acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulationAmerican Heart Journal, 1981
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981